LDOS — Leidos Holdings, Inc.

Summary of Leidos (LDOS) Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Revenue: $4.47 billion, up 7% year-over-year and 6% organically.
• Adjusted EBITDA: $616 million, up 3% year-over-year, with an adjusted EBITDA margin of 13.8%.
• Non-GAAP Diluted EPS: Increased by 4% to $3.05.
• Operating Cash Flow: $711 million, with a free cash flow of $680 million, resulting in a free cash flow conversion ratio of 171%.
• Debt: $4.7 billion, with a gross leverage ratio of 2x; no principal payments due until 2028.
• Share Repurchase: $100 million in shares repurchased; quarterly dividend increased to $0.43 per share, a 7.5% rise.

2. Strategic Updates and Business Highlights

• NorthStar 2030 Strategy: Focus on five growth pillars: Space and maritime, energy infrastructure, digital modernization and cyber, mission software, and managed health services.
• Energy Infrastructure Growth: Significant growth in engineering services for electric utilities, with expectations of over $1 trillion investment in U.S. energy infrastructure over the next decade.
• Defense Systems: Continued strong performance with an 11% year-over-year growth, driven by increased volumes in air defense and hypersonic missile programs.
• Recent Contracts: Rewon a $0.5 billion counterterrorism contract and received a large award for Kazakhstan's air traffic control modernization.
• Backlog: Funded backlog increased by 27% sequentially, indicating strong customer demand.

3. Forward Guidance and Outlook

• 2025 Guidance: Revenue guidance reaffirmed at $17 billion to $17.25 billion; adjusted EBITDA margin raised to high 13s; non-GAAP diluted EPS guidance increased by $0.30 to a range of $11.45 to $11.75.
• Pipeline: $69 billion in near-term opportunities, with $24 billion in bids awaiting adjudication.
• Investment Focus: Continued investment in technology and innovation, particularly in AI and defense capabilities.

4. Bad News, Challenges, or Points of Concern

• Government Shutdown: Potential impact on operations and decision-making processes; however, most programs remain unaffected.
• Market Dynamics: Ongoing government efficiency reviews pose moderate headwinds.
• Competitive Pressures: Increased competition in the health services sector, particularly with the introduction of a fourth provider in some regions.

5. Notable Q&A Insights

• M&A Strategy: Management indicated a more focused approach to M&A aligned with the NorthStar 2030 strategy, while maintaining a shareholder-friendly capital deployment strategy.
• Defense Systems Growth: Management expressed confidence in the Defense Systems segment, highlighting multiple franchise programs with significant potential value.
• Health & Civil Segment: Sustained performance expected, with ongoing investments in technology and innovation to maintain competitive advantage.
• Recompete Contracts: Key recompete contracts identified, including the VBA contract and others in the pipeline, with an emphasis on new business opportunities over recompetes for the upcoming year.

Overall, Leidos reported strong financial performance in Q3 2025, with robust growth across several segments, a solid balance sheet, and a positive outlook despite challenges posed by the government shutdown and competitive pressures.